Literature DB >> 33156197

Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink.

Lakshmi Panagiotakopoulos1, Natalie L McCarthy, Naomi K Tepper, Elyse O Kharbanda, Heather S Lipkind, Gabriela Vazquez-Benitez, David L McClure, Victoria Greenberg, Darios Getahun, Jason M Glanz, Allison L Naleway, Nicola P Klein, Jennifer C Nelson, Eric S Weintraub.   

Abstract

OBJECTIVE: To evaluate whether the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccinations in pregnancy are associated with increased risk of stillbirth.
METHODS: We performed a case-control study in the Vaccine Safety Datalink that was matched 1:4 on site, month, and year of last menstrual period, comparing the odds of vaccination in pregnancies that ended in stillbirth (defined as fetal loss at or after 20 weeks of gestation) compared with those that ended in live birth from January 1, 2012, to September 30, 2015. We included patients with singleton pregnancies that ended in stillbirth or live birth who had at least one prenatal care visit, pregnancy dating information, and continuous health plan enrollment for the duration of pregnancy. Medical records for all stillbirths were reviewed. We were statistically powered to detect an odds ratio (OR) of 1.37 when evaluating the association between influenza or Tdap vaccination and stillbirth. We also examined stillbirth rates in pregnant patients aged 14-49 years in the Vaccine Safety Datalink between 2007 and 2015.
RESULTS: In our matched analysis of 795 confirmed stillbirths in the case group and 3,180 live births in the control group, there was no significant association between influenza vaccination during pregnancy and stillbirth (343/795 [43.1%] stillbirths in the case group vs 1,407/3,180 [44.3%] live births in the control group, OR 0.94, adjusted OR 0.95, 95% CI 0.79-1.14, P=.54) and no significant association between Tdap vaccination during pregnancy and stillbirth (184/795 [23.1%] stillbirths in the case group vs 746/3,180 [23.5%] live births in the control group, OR 0.97, aOR 0.96, 95% CI 0.76-1.28, P=.91). From 2007 to 2015, the stillbirth rate in the Vaccine Safety Datalink was 5.2 per 1,000 live births and stillbirths.
CONCLUSION: No association was found between vaccination during pregnancy and the odds of stillbirth. These findings support the safety of ACIP recommendations for vaccination during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33156197      PMCID: PMC8108006          DOI: 10.1097/AOG.0000000000004166

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  29 in total

1.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-29       Impact factor: 17.586

2.  Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination.

Authors:  Jamie L Morgan; Sangameshwar R Baggari; Donald D McIntire; Jeanne S Sheffield
Journal:  Obstet Gynecol       Date:  2015-06       Impact factor: 7.661

3.  Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study.

Authors:  Terho Heikkinen; James Young; Erik van Beek; Henk Franke; Thomas Verstraeten; John G Weil; Giovanni Della Cioppa
Journal:  Am J Obstet Gynecol       Date:  2012-07-16       Impact factor: 8.661

4.  Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines.

Authors:  Britta Panda; Robert Stiller; Alexander Panda
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07-01

5.  Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine.

Authors:  Mary Ann Goss; Fabio Lievano; Karyn M Buchanan; Margaret M Seminack; Michael L Cunningham; Adrian Dana
Journal:  Vaccine       Date:  2015-04-11       Impact factor: 3.641

6.  Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes.

Authors:  Nikolai M Scheller; Björn Pasternak; Ditte Mølgaard-Nielsen; Henrik Svanström; Anders Hviid
Journal:  N Engl J Med       Date:  2017-03-30       Impact factor: 91.245

7.  The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.

Authors:  C E S Suzano; E Amaral; H K Sato; P M Papaiordanou
Journal:  Vaccine       Date:  2005-10-03       Impact factor: 3.641

8.  Association of influenza vaccination on decreased stillbirth rate.

Authors:  Alison C Wortman; Brian M Casey; Donald D McIntire; Jeanne S Sheffield
Journal:  Am J Perinatol       Date:  2015-01-21       Impact factor: 1.862

9.  Seasonal Trivalent Influenza Vaccination During Pregnancy and the Incidence of Stillbirth: Population-Based Retrospective Cohort Study.

Authors:  Annette K Regan; Hannah C Moore; Nicholas de Klerk; Saad B Omer; Geoffrey Shellam; Donna B Mak; Paul V Effler
Journal:  Clin Infect Dis       Date:  2016-03-30       Impact factor: 9.079

10.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Authors:  Lisa A Grohskopf; Elif Alyanak; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2019-08-23
View more
  2 in total

1.  A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals.

Authors:  Ann Lisa Arulappen; Monica Danial; Gaiyathri Shanmugam; Joo Thye Cheng; Mairin Dulasi; Ting Soo Chow
Journal:  Front Public Health       Date:  2022-05-23

2.  The Risk of Spontaneous Abortion Does Not Increase Following First Trimester mRNA COVID-19 Vaccination.

Authors:  Ioana Mihaela Citu; Cosmin Citu; Florin Gorun; Ioan Sas; Felix Bratosin; Andrei Motoc; Bogdan Burlea; Ovidiu Rosca; Daniel Malita; Oana Maria Gorun
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.